Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frode Selheim

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|February 24, 2022
The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione AxisShahin Sarowar, Davide Cirillo, Pablo Játiva, et al.
Proteomics|July 22, 2014
Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell linesElise Aasebø, Marc Vaudel, Olav Mjaavatten, et al.
Journal of Personalized Medicine|August 27, 2021
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient HeterogeneityIda Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, et al.
The Journal of Biological Chemistry|June 24, 2003
cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extensionAnne E Christensen, Frode Selheim, Johan de Rooij, et al.
Marine Drugs|February 1, 2013
Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from Streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cellsLene E Myhren, Gyrid Nygaard, Gro Gausdal, et al.
Signal Transduction and Targeted Therapy|June 27, 2019
Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cellsIna Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, et al.
Expert Opinion on Therapeutic Targets|June 12, 2018
Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparisonIna Nepstad, Kimberley J Hatfield, Elise Aasebø, et al.
Scientific Reports|August 20, 2017
Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expressionGyrid Nygaard, Lars Herfindal, Kathrine S Asrud, et al.
Journal of Clinical Medicine|September 9, 2023
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment ToxicitySushma Bartaula-Brevik, Calum Leitch, Maria Hernandez-Valladares, et al.
Cancers|March 21, 2020
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid LeukemiaElise Aasebø, Frode S Berven, Sushma Bartaula-Brevik, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|February 24, 2022
The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione AxisShahin Sarowar, Davide Cirillo, Pablo Játiva, et al.
Proteomics|July 22, 2014
Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell linesElise Aasebø, Marc Vaudel, Olav Mjaavatten, et al.
Journal of Personalized Medicine|August 27, 2021
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient HeterogeneityIda Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, et al.
The Journal of Biological Chemistry|June 24, 2003
cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extensionAnne E Christensen, Frode Selheim, Johan de Rooij, et al.
Marine Drugs|February 1, 2013
Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from Streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cellsLene E Myhren, Gyrid Nygaard, Gro Gausdal, et al.
Signal Transduction and Targeted Therapy|June 27, 2019
Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cellsIna Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, et al.
Expert Opinion on Therapeutic Targets|June 12, 2018
Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparisonIna Nepstad, Kimberley J Hatfield, Elise Aasebø, et al.
Scientific Reports|August 20, 2017
Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expressionGyrid Nygaard, Lars Herfindal, Kathrine S Asrud, et al.
Journal of Clinical Medicine|September 9, 2023
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment ToxicitySushma Bartaula-Brevik, Calum Leitch, Maria Hernandez-Valladares, et al.
Cancers|March 21, 2020
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid LeukemiaElise Aasebø, Frode S Berven, Sushma Bartaula-Brevik, et al.
Pageof 7